Kalbe Farma Tbk PT ADR (PTKFY)
Company Info
Highlights
$4.35B
$0.90
20.00
1.72
$33.11T
$13.20T
$4.88T
$12.00 - $23.72
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Kalbe Farma Tbk PT ADR (PTKFY) returned 7.84% year-to-date (YTD) and -4.64% over the past 12 months. Over the past 10 years, PTKFY returned -2.42% annually, underperforming the S&P 500 benchmark at 10.85%.
PTKFY
7.84%
12.50%
-3.13%
-4.64%
-4.97%
2.02%
-2.42%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of PTKFY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -7.01% | -16.07% | 5.22% | 16.72% | 12.50% | 7.84% | |||||||
| 2024 | -11.10% | 2.79% | -9.02% | 7.65% | 1.11% | 0.42% | 16.70% | 2.52% | -10.25% | -9.71% | -10.17% | -20.85% | |
| 2023 | 5.25% | 10.44% | -4.68% | -3.65% | 5.58% | -4.04% | -5.03% | -13.36% | -5.21% | -15.63% | |||
| 2022 | 4.49% | -1.36% | -2.10% | 0.59% | -1.21% | 2.79% | -0.26% | -2.07% | 9.48% | 8.72% | -1.35% | 1.08% | 19.49% |
| 2021 | 1.80% | -4.55% | 0.35% | -6.49% | 1.12% | 1.20% | -12.96% | 3.54% | 9.37% | 4.89% | 8.45% | -1.01% | 3.55% |
| 2020 | -9.98% | -14.95% | -28.18% | 35.15% | 3.88% | 17.02% | 3.10% | 3.20% | -5.35% | 0.73% | 4.51% | -4.24% | |
| 2019 | 8.33% | -5.39% | -2.31% | 2.44% | -14.65% | 15.34% | -0.62% | 14.41% | 0.36% | -2.32% | -7.37% | 7.52% | 12.12% |
| 2018 | -0.16% | -6.42% | -6.38% | -0.71% | -8.86% | -11.95% | 5.49% | 1.68% | 1.42% | -2.69% | 18.43% | -0.96% | -13.46% |
| 2017 | -3.43% | 5.64% | 0.74% | 3.66% | -3.49% | 6.95% | 6.80% | -1.57% | -3.55% | -4.56% | 0.27% | 5.30% | 12.34% |
| 2016 | 1.21% | 0.32% | 12.09% | -4.33% | -1.14% | 13.85% | 10.43% | 5.82% | -2.89% | 1.48% | -17.00% | 1.60% | 19.01% |
| 2015 | -0.36% | -5.15% | 2.14% | -2.92% | 1.58% | -9.71% | 2.67% | -7.58% | -21.27% | 11.32% | -5.52% | -2.99% | -34.49% |
| 2014 | 12.03% | 8.55% | 3.25% | 3.63% | -1.29% | 7.26% | 6.72% | -5.03% | -1.69% | 1.13% | 1.64% | 3.04% | 45.36% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PTKFY is 45, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Kalbe Farma Tbk PT ADR (PTKFY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Kalbe Farma Tbk PT ADR provided a 2.16% dividend yield over the last twelve months, with an annual payout of $0.39 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.39 | $0.39 | $0.52 | $0.48 | $0.39 | $0.36 | $0.36 | $0.36 | $0.33 | $0.28 | $0.29 | $0.29 |
Dividend yield | 2.16% | 2.32% | 2.41% | 1.85% | 1.76% | 1.63% | 1.55% | 1.70% | 1.33% | 1.24% | 1.51% | 0.99% |
Monthly Dividends
The table displays the monthly dividend distributions for Kalbe Farma Tbk PT ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.39 | |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.00 | $0.00 | $0.52 | |||
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.48 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.39 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.00 | $0.00 | $0.09 | $0.36 | |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.29 |
| 2014 | $0.29 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.29 |
Dividend Yield & Payout
Dividend Yield
Kalbe Farma Tbk PT ADR has a dividend yield of 2.16%, which is quite average when compared to the overall market.
Payout Ratio
Kalbe Farma Tbk PT ADR has a payout ratio of 42.60%, which is quite average when compared to the overall market. This suggests that Kalbe Farma Tbk PT ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Kalbe Farma Tbk PT ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Kalbe Farma Tbk PT ADR was 61.29%, occurring on Mar 23, 2020. Recovery took 140 trading sessions.
The current Kalbe Farma Tbk PT ADR drawdown is 38.05%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.29% | May 21, 2013 | 1372 | Mar 23, 2020 | 140 | Jan 26, 2023 | 1512 |
| -58.7% | Mar 17, 2023 | 123 | Apr 8, 2025 | — | — | — |
| -11.73% | Dec 17, 2012 | 15 | Jan 10, 2013 | 19 | Feb 13, 2013 | 34 |
| -11.06% | Mar 11, 2013 | 10 | Mar 22, 2013 | 19 | Apr 24, 2013 | 29 |
| -4.43% | May 1, 2013 | 2 | May 3, 2013 | 1 | May 13, 2013 | 3 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Kalbe Farma Tbk PT ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Kalbe Farma Tbk PT ADR, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Kalbe Farma Tbk PT ADR is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PTKFY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, PTKFY has a P/E ratio of 20.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PTKFY compared to other companies in the Drug Manufacturers - General industry. PTKFY currently has a PEG ratio of 1.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PTKFY relative to other companies in the Drug Manufacturers - General industry. Currently, PTKFY has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PTKFY in comparison with other companies in the Drug Manufacturers - General industry. Currently, PTKFY has a P/B value of 2.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |